Peng Cao

13.0k total citations · 2 hit papers
401 papers, 9.1k citations indexed

About

Peng Cao is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Peng Cao has authored 401 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 196 papers in Molecular Biology, 59 papers in Oncology and 51 papers in Immunology. Recurrent topics in Peng Cao's work include MicroRNA in disease regulation (15 papers), Pharmacological Effects of Natural Compounds (14 papers) and Monoclonal and Polyclonal Antibodies Research (14 papers). Peng Cao is often cited by papers focused on MicroRNA in disease regulation (15 papers), Pharmacological Effects of Natural Compounds (14 papers) and Monoclonal and Polyclonal Antibodies Research (14 papers). Peng Cao collaborates with scholars based in China, United States and Spain. Peng Cao's co-authors include Xueting Cai, Wuguang Lu, Mei Li, Jian Liao, Zhenfeng Liu, Chunping Hu, Wenrui Chang, Min Wang, Xiaodong Su and Yazhou Lou and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Peng Cao

379 papers receiving 9.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Structure of spinach photosystem II–LHCII supercomplex at 3.2 Å resolution

2016 452 citations Peng Cao et al. profile →
Diabetic neuropathy: cutting-edge research and future directions

2025 26 citations Peng Cao et al. profile →

Peers

Countries citing papers authored by Peng Cao

Since Specialization

Citations

This map shows the geographic impact of Peng Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Cao more than expected).

Fields of papers citing papers by Peng Cao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Cao. The network helps show where Peng Cao may publish in the future.

Co-authorship network of co-authors of Peng Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Peng Cao. A scholar is included among the top collaborators of Peng Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Cao. Peng Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Manganese-engineered Lactobacillus Reuteri with enhanced antitumor and immunomodulatory activities for colorectal cancer prevention and treatment 2025 ·Nature Communications ·Peng Cao, (unknown), Yuyu Li, Honglian Guo, (unknown), (unknown), (unknown), Wei Chen, Lin Wang, Zheng Wang	0
2	Soufeng sanjie formula alleviates osteoarthritis by inhibiting macrophage M1 polarization and modulating intestinal metabolites 2024 ·Journal of Ethnopharmacology ·Bo Fan, Qingyu Liu, Yan Yang, Wenhui Wu, Qingyun Wei, Jie Yang, Chunping Hu, Xiaoyan Sun, Peng Cao	4
3	Processed Buthus martensii Karsch scorpions ameliorate diet-induced NASH in mice by attenuating Kv1.3-mediated macrophage activation 2024 ·Journal of Ethnopharmacology ·(unknown), Ming Sang, W. Xu, Yonggen Chen, Zhiheng Wang, Yuxin Zhang, Wuguang Lu, Peng Cao	1
4	Do specific platforms affect the relationship between digital technology application and green transformation? Evidence from different platforms in China 2024 ·Finance research letters ·Peng Cao	1
5	Exenatide reduces atrial fibrillation susceptibility by inhibiting hKv1.5 and hNav1.5 channels 2024 ·Journal of Biological Chemistry ·Qian Zhou, Guoliang Hao, (unknown), Bin Chen, Wuguang Lu, (unknown), Rongling Zhong, Jiao Chen, Juan Ye, Jianping Shen, Peng Cao	4
6	TRPV1 analgesics disturb core body temperature via a biased allosteric mechanism involving conformations distinct from that for nociception 2024 ·Neuron ·(unknown), (unknown), (unknown), (unknown), Yuhao Gao, S. Di, Yuntao Lei, (unknown), Xiaona Yang, (unknown), (unknown), Peng Cao, Changzhu Li, Michael X. Zhu, Mengyang Sun, (unknown)	9
7	Homologous polydopamine ameliorates haemolysis of melittin for enhancing its anticancer efficacy 2024 ·Journal of Materials Chemistry B ·(unknown), Qingyun Wei, (unknown), (unknown), Tao Cao, Tianbao Chen, Peng Cao, (unknown)	3
8	BmKK2, a thermostable Kv1.3 blocker from Buthus martensii Karsch (BmK) scorpion, inhibits the activation of macrophages via Kv1.3-NF-κB- NLRP3 axis 2023 ·Journal of Ethnopharmacology ·Zhiheng Wang, Ming Sang, Yuxin Zhang, Shengjun Chen, Song Li, Yonggen Chen, (unknown), Qian Zhou, W. Xu, Chenglei Zhao, Dawei Wang, Wuguang Lu, Peng Cao	13
9	Smart hydrothermally responsive microneedle for topical tumor treatment 2023 ·Journal of Controlled Release ·(unknown), Honglian Guo, Xiuli Chen, (unknown), (unknown), Peng Cao, (unknown), Fei Xiao, Di Wu, Wei Chen, Lin Wang, Zheng Wang	26
10	Long non-coding RNA GNAS-AS1 knockdown inhibits proliferation and epithelial–mesenchymal transition of lung adenocarcinoma cells via the microRNA-433-3p/Rab3A axis 2023 ·Open Medicine ·Jing He, (unknown), Peng Cao, Jinxia Zhou, (unknown), Na Li	1
11	Baseline differences in metabolic profiles of patients with lung squamous cell carcinoma responding or not responding to treatment with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) 2023 ·SHILAP Revista de lepidopterología ·Peng Cao, Qilin Zhang, Sanlan Wu, Mitchell A. Sullivan, Yifei Huang, Weijing Gong, (unknown), (unknown), Yu Zhang	3
12	Azeliragon inhibits PAK1 and enhances the therapeutic efficacy of AKT inhibitors in pancreatic cancer 2023 ·European Journal of Pharmacology ·Weikang Kong, (unknown), Tian Li, Jiao Chen, (unknown), Wenjing Ji, Chunli Zhang, Xueting Cai, Chunping Hu, Xiaoyan Sun, Peng Cao	4
13	Chronic cough relief by allosteric modulation of P2X3 without taste disturbance 2023 ·Nature Communications ·Chang-Run Guo, (unknown), Xing Zhou, Mengyang Sun, Tiantian Li, Yuntao Lei, Yuhao Gao, Qingquan Li, (unknown), (unknown), (unknown), (unknown), Changzhu Li, Peng Cao, Michael X. Zhu, Mingqiang Rong, Wenhui Wang, Ye Yu	11
14	Population Pharmacokinetics and Dosing Regimen Optimization of Linezolid in Cerebrospinal Fluid and Plasma of Post-operative Neurosurgical Patients 2022 ·Journal of Pharmaceutical Sciences ·(unknown), Yuefei Wang, (unknown), Yuan Zhu, Peng Cao, (unknown), (unknown)	6
15	Factors Influencing Medical Personnel to Work in Primary Health Care Institutions: An Extended Theory of Planned Behavior 2022 ·International Journal of Environmental Research and Public Health ·Huanhuan Jia, Jianxing Yu, Tianyu Feng, (unknown), Peng Cao, (unknown), Shang Gao, (unknown)	2
16	GSK1702934A and M085 directly activate TRPC6 via a mechanism of stimulating the extracellular cavity formed by the pore helix and transmembrane helix S6 2021 ·Journal of Biological Chemistry ·Peilin Yang, Xinghua Li, Jin Wang, Xuefei Ma, (unknown), (unknown), Wenhui Wang, Peng Cao, Michael X. Zhu, (unknown), Zhihong Xiao, Changzhu Li, Chang-Run Guo, Yuntao Lei, Ye Yu	14
17	Two radical-dependent mechanisms for anaerobic degradation of the globally abundant organosulfur compound dihydroxypropanesulfonate 2020 ·Proceedings of the National Academy of Sciences ·Jiayi Liu, Yifeng Wei, Lianyun Lin, Lin Teng, (unknown), Qiang Lü, (unknown), (unknown), Yaxin Li, (unknown), (unknown), Yangping Liu, Yanhong Liu, Peng Cao, Ee Lui Ang, Huimin Zhao, Zhiguang Yuchi, Yan Zhang	39
18	M2 Macrophage-Derived Exosomes Promote Angiogenesis and Growth of Pancreatic Ductal Adenocarcinoma by Targeting E2F2 2020 ·Molecular Therapy ·Yuhan Yang, Zengya Guo, Weiwei Chen, Xiaofeng Wang, Meng Cao, Xuan Han, Kundong Zhang, Buwei Teng, Jun Cao, Weidong Wu, Peng Cao, Chen Huang, Zhengjun Qiu	223
19	Chikusetsusaponin IVa Butyl Ester (CS-IVa-Be), a Novel IL6R Antagonist, Inhibits IL6/STAT3 Signaling Pathway and Induces Cancer Cell Apoptosis 2016 ·Molecular Cancer Therapeutics ·Jie Yang, Shihui Qian, Xueting Cai, Wuguang Lu, Chunping Hu, Xiaoyan Sun, Yang Yang, Qiang Yu, Shengyu Gao, Peng Cao	18
20	The Natural Diterpenoid Isoforretin A Inhibits Thioredoxin-1 and Triggers Potent ROS-Mediated Antitumor Effects 2016 ·Cancer Research ·Xiaoyan Sun, Wei‐Guang Wang, Chen Jiao, Xueting Cai, Jie Yang, Yang Yang, Huaijiang Yan, Xiaolan Cheng, Juan Ye, Wuguang Lu, Chunping Hu, Han‐Dong Sun, Jian‐Xin Pu, Peng Cao	53

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact